A randomized, double-blind study of the effect of RAR Gamma on lung function in patients with symptomatic emphysema secondary to alpha-1 antitrypsin deficiency
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Palovarotene (Primary)
- Indications Emphysema
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Acronyms REPAIR-Tier-II
- Sponsors Roche
- 08 Dec 2008 Status changed from active, no longer recruiting to completed.
- 23 Mar 2007 New trial record.